Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,966 | -20,166 | -20,061 | -11,573 | -24,873 |
| Depreciation Amortization | 6 | 10 | 12 | 13 | 14 |
| Accounts payable and accrued liabilities | -453 | -34 | 189 | 199 | 367 |
| Other Working Capital | 1,559 | 373 | -1,222 | -464 | 68 |
| Other Operating Activity | 2,569 | 1,849 | 2,720 | 861 | 1,186 |
| Operating Cash Flow | $-22,285 | $-17,968 | $-18,362 | $-10,964 | $-23,238 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 3,594 | 5,930 | 1,000 | 26,676 |
| PPE Investments | N/A | N/A | -7 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -3,594 | -6,380 | -1,315 |
| Investing Cash Flow | $0 | $3,594 | $2,329 | $-5,380 | $25,361 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -6 | -10 | -13 | -13 | 31 |
| Common Stock Issued | 23,002 | 23,535 | 19,329 | 18,884 | 2,936 |
| Financing Cash Flow | $22,996 | $23,525 | $19,316 | $18,871 | $2,967 |
| Beginning Cash Position | 23,867 | 14,716 | 11,433 | 8,906 | 3,816 |
| End Cash Position | 24,578 | 23,867 | 14,716 | 11,433 | 8,906 |
| Net Cash Flow | $711 | $9,151 | $3,283 | $2,527 | $5,090 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,285 | -17,968 | -18,362 | -10,964 | -23,238 |
| Capital Expenditure | 0 | N/A | -7 | N/A | N/A |
| Free Cash Flow | -22,285 | -17,968 | -18,369 | -10,964 | -23,238 |